SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NRXS

Neuraxis, INC (New York Stock Exchange Arca:NRXS)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$4.22-$0.28 (-6.22%)
 
Market cap
$59.9M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 9, 2023
Market Cap$59.90M+63.6%
Revenue (ttm)$6.53M+94.3%
Net Income-$12.29M-63.0%
EPS-$1.05-1.9%
Shares Out14.19M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume151,407
Open$4.40
Previous Close$4.50
Day's Range$4.22 - $4.45
52-Week Range$2.50 - $9.33
Beta1.38
AnalystsBuy
Price Target$8.00(+89.57%)
Earnings DateMar 18, 2027
-5.33% (1D)
No price history available.

About NRXS

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.

Address
11550 North Meridian Street, Carmel, IN, 46032, US
Market Cap
60 million
Employees
24
Industrial Classification
Biotechnology

Neuraxis, INC Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
11th Percentile Overall Score
NRXS InsiderScore:50 / 99

Neuraxis, INC scored higher than 11% of companies evaluated by InsiderBuying, and ranked 76th out of 110 stocks in the biotech sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at Neuraxis, INC bought $12.3K of stock across 3 purchases in the last 90 days, the largest of them $9.4K.

Stake Increase

The average purchase added about 9% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

Every buyer already held stock, so each purchase is an increase rather than a first position.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$1.43M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From NRXS’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-6.22%
5 Days
-20.38%
1 Month
-44.47%
6 Months
-42.82%
1 Year
+63.57%

$NRXS stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NRXS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NRXS's directors and management

Net Shares Purchased by Insiders−300k−150k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NRXS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

NRXS Revenue by Segment or Geography

NRXS's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New NRXS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NRXS from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NRXS

VTIVanguard Morningstar Total Stock Market ETF$1.25M
VXFVanguard Extended Market ETF$781.14K
IWCiShares Micro-Cap ETF$122.89K
BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF$70.00K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NRXS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
49.78
Analyst Ratings
32% of score
99
News & Sentiment
20% of score
78

News check: Record quarterly revenue with 150% YoY growth represents substantial business outperformance and positive earnings catalysts.

Recent Insider Activity

Buys
9
Sells
0
Buy Value
$1.43M
Distinct Buyers
5

Insider Score Trend Over Time

-13.0 since Oct 9
0255075100Oct 9 — Insider Score 62.8Oct 10 — Insider Score 62.9Oct 11 — Insider Score 62.9Oct 12 — Insider Score 63.5Oct 13 — Insider Score 63.3Oct 14 — Insider Score 63.2Oct 15 — Insider Score 62.6Oct 16 — Insider Score 62.7Oct 17 — Insider Score 62.2Oct 18 — Insider Score 62.6Oct 19 — Insider Score 62.4Oct 20 — Insider Score 62.5Oct 21 — Insider Score 62.1Oct 22 — Insider Score 62.0Oct 23 — Insider Score 62.8Oct 24 — Insider Score 62.6Oct 25 — Insider Score 62.7Oct 26 — Insider Score 62.5Oct 27 — Insider Score 62.5Oct 28 — Insider Score 61.8Oct 29 — Insider Score 61.7Oct 30 — Insider Score 61.5Oct 31 — Insider Score 61.4Nov 1 — Insider Score 61.5Nov 2 — Insider Score 61.5Nov 3 — Insider Score 61.1Nov 4 — Insider Score 60.7Nov 5 — Insider Score 60.2Nov 6 — Insider Score 59.6Nov 7 — Insider Score 59.3Nov 8 — Insider Score 59.3Nov 9 — Insider Score 59.6Nov 10 — Insider Score 58.6Nov 11 — Insider Score 58.4Nov 12 — Insider Score 57.5Nov 13 — Insider Score 56.5Nov 14 — Insider Score 55.8Nov 15 — Insider Score 55.9Nov 16 — Insider Score 55.7Nov 17 — Insider Score 55.0Nov 18 — Insider Score 53.2Nov 19 — Insider Score 51.9Nov 20 — Insider Score 50.9Nov 21 — Insider Score 49.7Nov 22 — Insider Score 49.8Oct 9Oct 31Nov 22

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF0.08%

Weight is the stock’s share of each fund’s holdings.